Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases

Abstract

This is a review article based on the international symposium report of the "US-Japan Conference on Advances in Oncology: Cancer and Infectious Diseases" held online on June 25, 2021, which provided an update on the association between oncology and infectious disease research from cutting-edge basic science to high-impact clinical trials.

The Dimensions of Reports From Around the World That Address Diversity in Oncology

“…1). Although the top six countries, United States (178), Japan (53), India (43), China (22), Canada (20) and Turkey (18), were the origins of two-thirds of the publications, our journal has published articles from a total of 52 countries throughout the world, reflecting the diversity of our publications (Fig. 2).…”

“…From Mexico, Hernandez-Ruiz et al reviewed the epidemiology of non-Hodgkin’s lymphoma [ 14 ], Fernandez-Ferreira et al reported that epithelial-cadherin expression is associated with better survival in invasive lobular breast cancer [ 15 ], Fernandez-Garza et al reviewed applications of personalized medicine in ovarian cancer [ 16 ], and Dupont et al reported the relationship of laterality to testicular germ cell tumor survival [ 17 ]. Lastly, we published a review article on a conference held at the Japan Embassy on cancer and infectious diseases between the United States and Japan [ 18 ].…”

Types of Cancer and Research Covered in World Journal of Oncology

“…The numbers roughly reflect the commonality of the cancer types, apart from common cancers like colorectal cancer and skin cancer including melanoma, about which few papers were published. In terms of the topics, our journal publishes articles that highlight racial and ethnic diversity [ 4 , 20 - 29 ] as we mentioned previously [ 30 ]. In addition, we have noticed that there has been a huge increase in cancer immunology and immunotherapy interest.…”